Obesity care in a post-COVID-19 world

In this webinar, we review the strong evidence supporting the major benefits of lifestyle change, pharmacological and surgical approaches to obesity, bearing in mind the profound impact that metabolic syndrome and obesity has on COVID-19 outcomes. As we re-focus and redesign health services after lockdown, it is becoming increasingly clear that prioritising obesity care will help protect our population during possible second and third waves of infection. 

Last modified: Thursday, 11 June 2020, 1:12 PM